Viewing data from:

ERYTHROMYCIN LACTOBIONATE

ANDA

ERYTHROMYCIN LACTOBIONATE | A062604 | ABRAXIS PHARMACEUTICAL PRODUCTS

2 strengths0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

APITORIA PHARMA PRIVATE LTDERYTHROMYCIN LACTOBIONATE

DMF 340722019

GLAND PHARMA LTDERYTHROMYCIN LACTOBIONATE

DMF 344262019

BIOPHORE INDIA PHARMACEUTICALS PVT LTDERYTHROMYCIN LACTOBIONATE

DMF 347502020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Nov 24, 1986

No patent or exclusivity listings for this strength.

#002 — EQ 1GM BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Nov 24, 1986